Overview

The National Health Act 1953 was enacted to provide a framework for the administration of health services and the regulation of health-related activities in Australia. This legislation was introduced to address the need for a cohesive and structured approach to healthcare delivery, ensuring that services were accessible, affordable, and of high quality. The Act was enacted by the Australian Parliament and has since been amended to adapt to changing healthcare needs and technological advancements. The Pharmaceutical Benefits Determination under subsection 84C(7) is a part of this Act, which aims to set the prices for pharmaceutical benefits, ensuring that they are fair and reflect the costs involved in their supply. This determination, as part of the National Health Act 1953, was created to regulate the pricing of pharmaceutical benefits, thereby ensuring that the costs for these benefits are transparent and reasonable. The Department of Health and Ageing is responsible for preparing and updating these determinations, which include setting the prices for both ready-prepared and extemporaneously-prepared pharmaceutical benefits. The policy objective behind these determinations is to maintain an equitable and efficient pharmaceutical benefits scheme, which provides affordable access to necessary medications for the Australian public.

Scope and Application

The Pharmaceutical Benefits Determination under subsection 84C(7) of the National Health Act 1953 sets the framework for determining the prices of pharmaceutical benefits supplied to consumers in Australia, and applies to all approved suppliers of pharmaceutical items listed under the Act. This includes both ready-prepared and extemporaneously-prepared pharmaceutical benefits, which are supplied by approved pharmacists. The Act applies nationally, affecting the pharmaceutical industry, healthcare providers, and consumers across the Commonwealth of Australia. The legislation specifies the price structure for these benefits, which comprises the Commonwealth price and an additional fee agreed with the Pharmacy Guild of Australia. This determination is complemented by various amendments and schedule updates, which refine and adjust the price components over time. The Act does not explicitly state exclusions or thresholds, but the prices are regulated to ensure they do not exceed the amount an approved supplier may charge under the Act. The application of this legislation is extended through subordinate instruments, which include the determinations and amendments noted in the Federal Register of Legislative Instruments.

Key Provisions

The Pharmaceutical Benefits Determination under subsection 84C(7) of the National Health Act 1953 lays out the pricing structure for pharmaceutical benefits available to the public through the Pharmaceutical Benefits Scheme (PBS). The primary operative sections of this determination set forth the methodology for calculating the price of pharmaceutical items, including the Commonwealth price for the supply of these items by approved pharmacists (section 4). The determination distinguishes between ready-prepared pharmaceutical benefits and extemporaneously-prepared pharmaceutical benefits, each having a specific additional fee that is added to the Commonwealth price (section 4(b)(i) and (ii)). This additional fee is agreed upon with the Pharmacy Guild of Australia and varies based on the type of pharmaceutical benefit. The price for these benefits is subject to the condition that it must not exceed the amount that an approved supplier may charge as stipulated under the Act (section 5). The Act imposes several obligations and requirements on the entities it governs, primarily focusing on the accurate calculation and adherence to the determined prices of pharmaceutical benefits. Pharmaceutical suppliers, including pharmacists, are required to ascertain the price of pharmaceutical benefits in a manner compliant with the provisions of subsections 84C(8)(a), (b), and (c) of the Act. Additionally, the agreement between the Commonwealth and the Pharmacy Guild of Australia regarding the additional fee must be respected and adhered to by all parties involved in the supply of pharmaceutical benefits. These obligations ensure that the pricing structure is transparent and consistently applied across the PBS. Failure to comply with the provisions of this determination can result in various penalties and legal consequences. Although the specific offences and penalties are not detailed in the determination itself, breaches of the National Health Act 1953 or related legislative instruments can lead to civil and criminal penalties. Civil penalties may include fines, while criminal penalties could encompass imprisonment, depending on the severity and nature of the breach. The exact penalties would be determined in accordance with other relevant sections of the Act and any subsidiary legislation. Non-compliance with the pricing and supply regulations outlined in this determination could potentially result in these penalties, making adherence to the Act crucial for all involved parties.